Ai Mediq is looking forward to seeing all our existing partners and new potential collaborators at joint booth of Ministry of Economy of Grand Duchy of Luxembourg tomorrow morning during opening of the Exhibition. The booth number remained the same A74 in Hall 3, so you should have no problems locating us. See you in Dusseldorf. P.S. Distributors wanted.
SummaryOvertraining syndrome (OTS) is a major concern among endurance athletes and is a leading cause in preventing them to perform for long periods. Intermittent exposure to hypoxia has been shown to be an effective way of improving perfor- mance without exercising. Aim of this pilot study was to evaluate intermittent hypoxia–hyperoxia training combined with light exercise as an intervention to facilitate athletes with OTS to…
Background: Repeated exposure to intermittent normobaric hypoxia improves exercise tolerance in cardiac patients. Little is known on the effects of intermittent normobaric hypoxia-hyperoxia exposure in coronary artery disease (CAD) patients (New York Heart Association II-III). Hypothesis: IHHT improves exercise tolerance, cardiometabolic profile, and quality of life in CAD patients. Methods: The study design was a nonrandomized, controlled, before-and-after trial. Forty-six CAD patients volunteered to take…
Aim: To compare a program based on intermittent hypoxia-hyperoxia training (IHHT) consisting of breathing hypoxic-hyperoxic gas mixtures while resting to a standard exercise-based rehabilitation program with respect to cardiorespiratory fitness (CRF) in older, comorbid cardiac outpatients. Materials and methods: Thirty-two cardiac patients with comorbidities were randomly allocated to IHHT and control (CTRL) groups. IHHT completed a 5-week program of exposure to hypoxia-hyperoxia while resting, CTRL…
Background: Although remote ischaemic preconditioning (RIP) provides protection against myocardial ischaemia and reperfusion injury during cardiac surgery, it is not widely used. Systemic intermittent hypoxic-hyperoxic training (IHHT) may be a suitable alternative. Methods: This is a prospective, single-centre, randomised controlled trial. 127 patients with ischaemic heart disease and indication for coronary artery bypass graft (CABG) surgery from the Cardiology Clinic IM Sechenov First Moscow State…
Bangkok, Thailand This February our leading instrument for delivering Interval Hypoxic Hyperoxic Therapy – ReOxy is presented to the attention of the general public in Bangkok, Thailand during the 24th Regional Conference of Dermatology taking place from 25th till 28th of February. ReOxy will be hosted by our long-standing Asian partner Indiba Asia at their booth S3 during the trade-show. Together we look forward to…
Currently, all efforts are focused on patients with acute diseases. All hospitals are crowded with severe patients with COVID-19 who need emergency care to save their lives. On the other hand, the number of people recovering from the virus is also steadily growing. Indeed, most of the patients have mild symptoms and it is expected that they will not have any complications after recovery. Nevertheless,…
It is was our pleasure to take part in the meeting and present the Intermittent Hypoxic Training Method in one of the well-known Liliane Goschy-FRITZ Institute in Baden-Baden, Germany on the 15th if July 2020. Liliane Goschy-FRITZ Institute provides a unique range of service areas for a healthy, powerful, and aesthetic body, individually combined in a flexible structure: a holistic concept of physiotherapy, personal training,…
Luxembourg, 23rd November Ai Mediq S.A. is pleased to announce the new stage of scientific cooperation with the Universitätsklinikum Hamburg-Eppendorf (UKE). Together with Dr. Sina Cathérine Rosenkranz we will be looking into potential perspectives of Interval Hypoxic Therapy in the treatment of multiple sclerosis. The pilot clinical trial will be conducted by the Institut für Neuroimmunologie und Multiple Sklerose (INIMS) and will be performed under the supervision of Prof.Dr.med.…
